|28.95||-0.3000||-1.03%||Vol 49.96K||1Y Perf 51.28%|
|Apr 19th, 2021 12:00 DELAYED|
|- -%||- -|
|Target Price||41.10||Analyst Rating||Strong Buy 1.00|
|Potential %||42.41||Finscreener Ranking||★★ — -|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★★ 50.82|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★ 44.91|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||— -|
|Market Cap||4.22B||Earnings Rating||Neutral|
|Price Range Ratio 52W %||57.00||Earnings Date||4th Mar 2021|
Today's Price Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||-|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||135.95K|
|Avg. Monthly Volume||146.41K|
|Avg. Quarterly Volume||227.82K|
Hutchison China MediTech Limited (NASDAQ: HCM) stock closed at 29.25 per share at the end of the most recent trading day (a -0.44% change compared to the prior day closing price) with a volume of 126.54K shares and market capitalization of 4.22B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 853 people. Hutchison China MediTech Limited CEO is Christian Hogg.
The one-year performance of Hutchison China MediTech Limited stock is 51.28%, while year-to-date (YTD) performance is -8.65%. HCM stock has a five-year performance of 116.99%. Its 52-week range is between 18.28 and 37, which gives HCM stock a 52-week price range ratio of 57.00%
Hutchison China MediTech Limited currently has a PE ratio of -31.50, a price-to-book (PB) ratio of 8.42, a price-to-sale (PS) ratio of 20.77, a price to cashflow ratio of 5 143.20, a PEG ratio of 2.32, a ROA of -20.44%, a ROC of -30.23% and a ROE of -31.52%. The company’s profit margin is -50.67%, its EBITDA margin is -67.20%, and its revenue ttm is $205.40 Million , which makes it $1.41 revenue per share.
Of the last four earnings reports from Hutchison China MediTech Limited, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Hutchison China MediTech Limited’s next earnings report date is -.
The consensus rating of Wall Street analysts for Hutchison China MediTech Limited is Strong Buy (1), with a target price of $41.1, which is +42.41% compared to the current price. The earnings rating for Hutchison China MediTech Limited stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Hutchison China MediTech Limited has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Hutchison China MediTech Limited has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.16, ATR14 : 1.60, CCI20 : 90.18, Chaikin Money Flow : 0.17, MACD : -1.09, Money Flow Index : 66.76, ROC : 4.20, RSI : 37.49, STOCH (14,3) : 79.42, STOCH RSI : 0.59, UO : 64.48, Williams %R : -20.58), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Hutchison China MediTech Limited in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
This could take some time, please wait.